en
Feedback
Respiratory Module | MW

Respiratory Module | MW

Open in Telegram

Respiratory Module Data ู„ู…ุดุงุฑูƒุฉ ุงู„ู‚ู†ุงุฉ https://t.me/Resp_Module ุงู„ุจูˆุช ู„ู„ูˆุตูˆู„ ุงู„ุณุฑูŠุน ู„ู„ุฏุงุชุง https://t.me/Medicine_way_bot?start=mb1029 ุงู„ู‚ู†ุงุฉ ุงู„ุฑุฆูŠุณูŠุฉ - @Medicine_Way2

Show more

๐Ÿ“ˆ Analytical overview of Telegram channel Respiratory Module | MW

Channel Respiratory Module | MW (@resp_module) in the Arabic language segment is an active participant. Currently, the community unites 17 196 subscribers, ranking 1 365 in the Medicine category and 4 334 in the Saudi Arabia region.

๐Ÿ“Š Audience metrics and dynamics

Since its creation on ะฝะตะฒั–ะดะพะผะพ, the project has demonstrated rapid growth, gathering an audience of 17 196 subscribers.

According to the latest data from 18 June, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by 130 over the last 30 days and by -1 over the last 24 hours, overall reach remains high.

  • Verification status: Not verified
  • Engagement rate (ER): The average audience engagement rate is 4.00%. Within the first 24 hours after publication, content typically collects N/A% reactions from the total number of subscribers.
  • Post reach: On average, each post receives 0 views. Within the first day, a publication typically gains 0 views.
  • Reactions and interaction: The audience actively supports content: the average number of reactions per post is 0.
  • Thematic interests: Content is focused on key topics such as ู…ูŽุงุฏูŽู‘ุฉ, ู…ูŽุฌู…ูŽุน, ูƒูุชูŽุงุจ, ู…ูŽุฏููŠูู‘ูˆู„, ู…ูŽุฏููŠูู‘ู„.

๐Ÿ“ Description and content policy

The author describes the resource as a platform for expressing subjective opinions:
โ€œRespiratory Module Data ู„ู…ุดุงุฑูƒุฉ ุงู„ู‚ู†ุงุฉ https://t.me/Resp_Module ุงู„ุจูˆุช ู„ู„ูˆุตูˆู„ ุงู„ุณุฑูŠุน ู„ู„ุฏุงุชุง https://t.me/Medicine_way_bot?start=mb1029 ุงู„ู‚ู†ุงุฉ ุงู„ุฑุฆูŠุณูŠุฉ - @Medicine_Way2โ€

Thanks to the high frequency of updates (latest data received on 19 June, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Medicine category.

17 196
Subscribers
-124 hours
+157 days
+13030 days
Posts Archive
39 - L7 , Diseases of pulmonary vasculatures , Patho.mp4 Quality : ๐ŸŽฌ 480p

38 - L6 , Restrictive lung disease (Atlectasis) and Acute adult respiratory distress syndrome (ARDS)patho.mp4 Quality : ๐ŸŽฌ 480p

37 - L5, bronchiectasis , Patho.mp4 Quality : ๐ŸŽฌ 480p

36 - Tut, Lung volumes and capacities, physio.mp4 Quality : ๐ŸŽฌ 480p

35 - L3 , Antifungal and antiviral drugs , Pharma.mp4 Quality : ๐ŸŽฌ 480p

34 - L6 , Viral respiratory tract infections 2 , Micro.mp4 Quality : ๐ŸŽฌ 480p

33 - L7, Fungal infections, Micro.mp4 Quality : ๐ŸŽฌ 480p

32 - L5 viral respiratory tract infection 1 , Micro.mp4 Quality : ๐ŸŽฌ 480p

31 - L2 , Antituberculous drugs , Pharma.mp4 Quality : ๐ŸŽฌ 480p

30 - L4 , Mycobacterium tuberculosis , Micro.mp4 Quality : ๐ŸŽฌ 480p

29 - Tutorial 2 , Lung surfactant & LโงธS ratio binding of hemoglobin to oxygen , Bio.mp4 Quality : ๐ŸŽฌ 480p

28 - L3 part 2, Lower respiratory tract infections, micro.mp4 Quality : ๐ŸŽฌ 480p

27 - L3 part 1, lower respiratory tract infections, micro.mp4 Quality : ๐ŸŽฌ 480p

26 - L1 part 3, drugs used in ttt of pulmonary infections , Pharma.mp4 Quality : ๐ŸŽฌ 480p

25 - L1 part 2, drugs used in ttt of pulmonary infections , Pharma.mp4 Quality : ๐ŸŽฌ 480p

24 - L3 ,The pathology of pulmonary microbial infection,patho.mp4 Quality : ๐ŸŽฌ 480p

23 - L2 , Upper respiratory diseases (2) (Tonsil & larynx),patho.mp4 Quality : ๐ŸŽฌ 480p

22 - L1, Upper respiratory diseases (1), Nose and pharynx, Patho..mp4 Quality : ๐ŸŽฌ 480p

21 - L1 part1, Drug used in treatment of pulmonary infection , Pharma.mp4 Quality : ๐ŸŽฌ 480p

20 - CBL 1, bronchial asthma, pharma.mp4 Quality : ๐ŸŽฌ 480p